thromboxane-b2 and Nutrition-Disorders

Zinc has been implicated in regulation of some aspects of prostaglandin (PG) metabolism. Effects of zinc deficiency, on PG synthesis and secretion were examined. Weanling rats were fed a control (adequate in zinc) or a zinc-deficient diet for 30 days. A third group was pair-fed to the zinc-deficient group with the control diet. The rats were anesthetized with ether, and tissues were excised for analysis. Zinc concentrations were measured in plasma, gut contents, gut mucosa, liver, lung and tibia. Prostaglandins F2alpha, E1, E2, thromboxane B2 (TXB2), 6-keto PGF1alpha (metabolite of PGI2, met I2) and 13, 14-dihydro-15 keto PGF2alpha (met F2alpha) were measured by radioimmunoassay. The results indicate that, with the exception of gut contents, in most organs studied and for most PG measured, food restriction is as effective in reducing PG level as zinc deficiency. In the gut contents, however, there was a positive correlation between zinc and PGE1 concentrations, and zinc deficiency decreased PGE1, PGF2alpha and PGI2 metabolite levels beyond food restriction. The decrease in PG concentrations of gut contents without any change in their mucosal concentrations suggests an active process of PG secretion involving zinc. In addition, in serum from clotted blood, zinc deficiency increased the level of met F2alpha (p less than 0.05), suggesting that zinc might be involved in control of PG levels by changing PG degradation rate.

Topics: Alprostadil; Animals; Dinoprost; Dinoprostone; Epoprostenol; Male; Nutrition Disorders; Organ Specificity; Prostaglandins; Prostaglandins E; Prostaglandins F; Rats; Rats, Inbred Strains; Thromboxane B2; Tissue Distribution; Zinc